Companies /Healthcare

Atricure Inc

NASDAQ: ATRC Medical Instruments & Supplies
$58.97
▼ $0.33 (−0.56%) today
Markets closed · 4:55pm ET

ATRC at a Glance

Valuation
Market cap
$3.0B
P/E ratio
282.4
Profitability
Revenue (TTM)
$569.6M
Profit margin
1.9%
EPS (TTM)
$0.21
Price
52-week range
$25 – $62
Street target
$57.56
Earnings
Next report
Nov 3, 2026

Headquartered in Mason, OH Fiscal year ends December NASDAQ: ATRC atricure.com

About AtriCure

AtriCure, Inc. is a medical device company that provides innovative surgical technologies for the treatment of atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. Afib affects more than 59 million people worldwide. The company's product portfolio includes the Isolator Synergy Ablation System (the first FDA-approved device for treating persistent Afib), the AtriClip Left Atrial Appendage Exclusion System (the most widely sold LAA management devices worldwide), the Hybrid AF Therapy for minimally invasive treatment of long-standing persistent Afib, and cryoICE cryoSPHERE and cryoXT probes for temporary ablation of peripheral nerves to block pain in cardiac, thoracic, and amputation procedures. The company sells its products in the United States and internationally through direct sales and independent distributors. AtriCure is actively advancing clinical trials including BoxX-NoAF and LeAAPS to expand the evidence base and addressable market for its cardiac surgery technologies. Updated

Latest Activity

House trade disclosureGilbert Ray Cisneros, Jr.U.S. Representative (House), California
  • ABTAbbott Laboratories Common Stock (ABT)Buy$1K – $15KSep 18
  • AEIS150 Main Street Trust > Bank of America Advanced Energy Industries, Inc. - CommoBuy$1K – $15KSep 29
  • ALKS150 Main Street Trust > Bank of America Alkermes plc - Ordinary Shares (ALKS)Buy$1K – $15KSep 29
  • ALGM150 Main Street Trust > Bank of America Allegro MicroSystems, Inc. - Common StocBuy$1K – $15KSep 29
  • APP150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StBuy$1K – $15KSep 18
  • ATRC150 Main Street Trust > Bank of America AtriCure, Inc. - Common Stock (ATRC)Partial sell$1K – $15KSep 29
  • BCPCBalchem Corporation - Common Stock (BCPC)Buy$1K – $15KSep 17
  • BHE150 Main Street Trust > Bank of America Benchmark Electronics, Inc. Common StockBuy$15K – $50KOct 1
+ 49 more trades in this filing
Made public 39 days after the earliest trade

A former Pentagon undersecretary just disclosed 57 trades in one filing, with the heaviest buying in semiconductors and electronics manufacturing: NXP, ON Semiconductor and Benchmark Electronics all picked up in size. The disclosure landed 39 days after the earliest trade.

Read more
House trade disclosureGilbert Ray Cisneros, Jr.
  • AMDAdvanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
  • AGIO150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
  • APH150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
  • APG150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
  • APP150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
  • AORT150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
  • ATRCAtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
  • BSX150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
+ 42 more trades in this filing
Made public 37 days after the earliest trade

Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.

Read more

ATRC Coverage

Frequently Asked Questions

What does AtriCure do?

AtriCure, Inc. is a medical device company that provides innovative surgical technologies for the treatment of atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. Afib affects more than 59 million people worldwide.

What is the ATRC stock price target?

The Wall Street consensus 12-month price target for ATRC is $57.56.